Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 97
Filter
2.
Methods Mol Biol ; 2447: 205-220, 2022.
Article in English | MEDLINE | ID: mdl-35583784

ABSTRACT

Deciphering the molecular mechanisms underlying the regulation of the ATG4 protease is essential to understand the regulation of ATG8 lipidation, a key step in the biogenesis of the autophagosome and hence in autophagy progression. Here, we describe two complementary approaches to monitor ATG4 proteolytic activity in the model green alga Chlamydomonas reinhardtii: an in vitro assay using recombinant ATG4 and recombinant ATG8 as substrate, and a cell-free assay using soluble total protein extract from Chlamydomonas and recombinant Chlamydomonas ATG8 as substrate. Both assays are followed by non-reducing SDS-PAGE and immuno-blot analysis. Given the high evolutionary conservation of the ATG8 maturation process, these assays have also been validated to monitor ATG4 activity in yeast using Chlamydomonas ATG8 as substrate.


Subject(s)
Chlamydomonas reinhardtii , Chlamydomonas , Microalgae , Autophagy/physiology , Autophagy-Related Protein 8 Family/metabolism , Autophagy-Related Proteins/metabolism , Chlamydomonas reinhardtii/genetics , Chlamydomonas reinhardtii/metabolism , Microalgae/metabolism , Microtubule-Associated Proteins/metabolism , Peptide Hydrolases/metabolism , Saccharomyces cerevisiae/metabolism
4.
Plant Cell ; 32(12): 3902-3920, 2020 12.
Article in English | MEDLINE | ID: mdl-33037147

ABSTRACT

Hydrogen sulfide is a signaling molecule that regulates essential processes in plants, such as autophagy. In Arabidopsis (Arabidopsis thaliana), hydrogen sulfide negatively regulates autophagy independently of reactive oxygen species via an unknown mechanism. Comparative and quantitative proteomic analysis was used to detect abscisic acid-triggered persulfidation that reveals a main role in the control of autophagy mediated by the autophagy-related (ATG) Cys protease AtATG4a. This protease undergoes specific persulfidation of Cys170 that is a part of the characteristic catalytic Cys-His-Asp triad of Cys proteases. Regulation of the ATG4 activity by persulfidation was tested in a heterologous assay using the Chlamydomonas reinhardtii CrATG8 protein as a substrate. Sulfide significantly and reversibly inactivates AtATG4a. The biological significance of the reversible inhibition of the ATG4 by sulfide is supported by the results obtained in Arabidopsis leaves under basal and autophagy-activating conditions. A significant increase in the overall ATG4 proteolytic activity in Arabidopsis was detected under nitrogen starvation and osmotic stress and can be inhibited by sulfide. Therefore, the data strongly suggest that the negative regulation of autophagy by sulfide is mediated by specific persulfidation of the ATG4 protease.


Subject(s)
Abscisic Acid/metabolism , Arabidopsis Proteins/metabolism , Arabidopsis/physiology , Autophagy-Related Proteins/metabolism , Cysteine Proteases/metabolism , Proteomics , Arabidopsis/enzymology , Arabidopsis/genetics , Arabidopsis Proteins/genetics , Autophagy , Autophagy-Related Proteins/genetics , Cysteine Proteases/genetics , Nitrogen/metabolism , Reactive Oxygen Species/metabolism , Signal Transduction , Sulfides/metabolism
5.
Clin Transl Oncol ; 22(12): 2364-2368, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32449128

ABSTRACT

BACKGROUND: There are no large reported series determining the Covid-19 cancer patient's characteristics. We determine whether differences exist in cumulative incidence and mortality of Covid-19 infection between cancer patients and general population in Madrid. MATERIAL AND METHODS: We reviewed 1069 medical records of all cancer patients admitted at Oncology department between Feb 1 and April 7, 2020. We described Covid-19 cumulative incidence, treatment outcome, mortality, and associated risk factors. RESULTS: We detected 45/1069 Covid-19 diagnoses in cancer patients vs 42,450/6,662,000 in total population (p < 0.00001). Mortality rate: 19/45 cancer patients vs 5586/42,450 (p = 0.0001). Mortality was associated with older median age, adjusted by staging and histology (74 vs 63.5 years old, OR 1.06, p = 0.03). Patients who combined hydroxychloroquine and azithromycin presented 3/18 deaths, regardless of age, staging, histology, cancer treatment and comorbidities (OR 0.02, p = 0.03). CONCLUSION: Cancer patients are vulnerable to Covid-19 with an increase in complications. Combined hydroxychloroquine and azithromycin is presented as a good treatment option.


Subject(s)
Coronavirus Infections/complications , Coronavirus Infections/mortality , Neoplasms/complications , Neoplasms/epidemiology , Pneumonia, Viral/complications , Pneumonia, Viral/mortality , Aged , Azithromycin/therapeutic use , Betacoronavirus/isolation & purification , COVID-19 , Coronavirus Infections/diagnosis , Coronavirus Infections/drug therapy , Drug Combinations , Female , Humans , Hydroxychloroquine/therapeutic use , Incidence , Male , Middle Aged , Neoplasms/pathology , Pandemics , Pneumonia, Viral/diagnosis , Pneumonia, Viral/drug therapy , Risk Factors , SARS-CoV-2 , Spain/epidemiology , Treatment Outcome
6.
J Hosp Infect ; 100(4): 451-455, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30179655

ABSTRACT

Mycobacterium chimaera is involved in a worldwide alert due to contaminated heater-cooler units. A real-time polymerase chain reaction (RT-PCR)-based procedure was implemented to survey undetected cases of M. chimaera infection. PCR was negative in the 59 prosthetic heart valves from patients with PCR-16SrRNA-negative infective endocarditis. PCR identified M. chimaera in one of 15 clinically significant retrospective Mycobacterium avium-Mycobacterium intracellulare complex isolates, which corresponded to a patient who had undergone heart valve replacement in a different institution. Whole-genome sequencing demonstrated that he was the first case in Spain with involvement of the strain responsible for the global outbreak. These results highlight the relevance of retrospective tracking for undetected M. chimaera infections.


Subject(s)
Mycobacterium Infections, Nontuberculous/diagnosis , Nontuberculous Mycobacteria/isolation & purification , Prosthesis-Related Infections/diagnosis , Real-Time Polymerase Chain Reaction , Aged , Animals , Heart Valve Prosthesis/adverse effects , Humans , Male , Mycobacterium Infections, Nontuberculous/microbiology , Nontuberculous Mycobacteria/genetics , Prosthesis-Related Infections/microbiology , Retrospective Studies , Spain/epidemiology , Whole Genome Sequencing
7.
Materials (Basel) ; 11(9)2018 Aug 22.
Article in English | MEDLINE | ID: mdl-30135371

ABSTRACT

The term additive manufacturing (AM) groups together a set of technologies with similar characteristics forming part of the Fourth Industrial Revolution. AM is being developed globally, as evidenced by the standards published by and the agreements between the ISO and the ASTM in 2013. The purpose of this paper is to anticipate the main changes that will occur in AM by 2030 as forecast by more than 100 Spanish experts through Delphi prospection performed in 2018. In this way, the areas, aspects, and business models with the greatest probabilities of occurrence are obtained. The need for technical experts with specific knowledge and skills requires changes to current training syllabuses. Such changes will enable students to have the profiles foreseen in these job trends. The encouragement of STEAM (Science, Technology, Engineering, Arts, and Mathematics) training through the introduction of AM in study plans may be an appropriate alternative. Finally, the consequences of the Fourth Industrial Revolution for the employment market and on jobs, particularly in Spain, are set out and the latest Spanish Research, Development, and Innovation (R&D + I) plans are summarized as the framework for the possible implementation and development of AM.

8.
J Viral Hepat ; 25(6): 699-706, 2018 06.
Article in English | MEDLINE | ID: mdl-29377515

ABSTRACT

Little data are available on renal toxicity exerted by direct-acting antivirals (DAAs) in real life. The aim of this study was to assess the impact of direct-acting antivirals against hepatitis C virus infection currently used in Spain and Portugal on the estimated glomerular filtration rate (eGFR) in clinical practise. From an international, prospective multicohort study, patients treated with DAAs for at least 12 weeks and with eGFR ≥30 mL/min per 1.73 m2 at baseline were selected. eGFR was determined using the CKD-EPI formula. A total of 1131 patients were included; 658 (58%) were HIV/HCV-coinfected patients. Among the 901 patients treated for 12 weeks, median (interquartile range) eGFR was 100 (87-107) at baseline vs 97 (85-105) mL/min per 1.73 m2 at week 12 of follow-up (FU12) post-treatment (P < .001). For HIV-coinfected subjects who received tenofovir plus a ritonavir-boosted HIV protease inhibitor (PI/r), baseline vs FU12 eGFR were 104 (86-109) vs 104 (91-110) mL/min per 1.73 m2 (P = .913). Among subjects receiving ombitasvir/paritaprevir with or without dasabuvir, eGFR did not show any significant change. Of 1100 subjects with eGFR >60 mL/min per 1.73 m2 at baseline, 22 (2%) had eGFR <60 mL/min per 1.73 m2 at FU12, but none presented with eGFR <30 mL/min per 1.73 m2 . In conclusion, eGFR slightly declines during therapy with all-oral DAAs and this effect persists up to 12 weeks after stopping treatment in subjects with normal to moderately impaired renal function, regardless of HIV status. Concomitant use of tenofovir plus PI/r does not seem to have an impact on eGFR.


Subject(s)
Antiviral Agents/administration & dosage , Antiviral Agents/adverse effects , Glomerular Filtration Rate , Hepatitis C, Chronic/complications , Hepatitis C, Chronic/drug therapy , 2-Naphthylamine , Anilides/administration & dosage , Anilides/adverse effects , Carbamates/administration & dosage , Carbamates/adverse effects , Cyclopropanes , Female , HIV Infections/complications , HIV Infections/drug therapy , Humans , Lactams, Macrocyclic , Macrocyclic Compounds/administration & dosage , Macrocyclic Compounds/adverse effects , Male , Middle Aged , Portugal , Proline/analogs & derivatives , Prospective Studies , Retrospective Studies , Spain , Sulfonamides/administration & dosage , Sulfonamides/adverse effects , Treatment Outcome , Uracil/administration & dosage , Uracil/adverse effects , Uracil/analogs & derivatives , Valine
9.
Sci Rep ; 6: 31819, 2016 08 22.
Article in English | MEDLINE | ID: mdl-27545976

ABSTRACT

The chikungunya virus (CHIKV) has become a substantial global health threat due to its massive re-emergence, the considerable disease burden and the lack of vaccines or therapeutics. We discovered a novel class of small molecules ([1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones) with potent in vitro activity against CHIKV isolates from different geographical regions. Drug-resistant variants were selected and these carried a P34S substitution in non-structural protein 1 (nsP1), the main enzyme involved in alphavirus RNA capping. Biochemical assays using nsP1 of the related Venezuelan equine encephalitis virus revealed that the compounds specifically inhibit the guanylylation of nsP1. This is, to the best of our knowledge, the first report demonstrating that the alphavirus capping machinery is an excellent antiviral drug target. Considering the lack of options to treat CHIKV infections, this series of compounds with their unique (alphavirus-specific) target offers promise for the development of therapy for CHIKV infections.


Subject(s)
Antiviral Agents/pharmacology , Chikungunya virus/genetics , Pyrimidinones/pharmacology , Viral Nonstructural Proteins/genetics , Amino Acid Substitution , Animals , Antiviral Agents/chemistry , Chikungunya virus/drug effects , Chikungunya virus/metabolism , Chlorocebus aethiops , Drug Resistance, Viral/drug effects , Encephalomyelitis, Equine/virology , Horses , Molecular Structure , Pyrimidinones/chemistry , Small Molecule Libraries/chemistry , Small Molecule Libraries/pharmacology , Vero Cells , Viral Nonstructural Proteins/antagonists & inhibitors , Viral Nonstructural Proteins/metabolism
10.
J Mol Graph Model ; 68: 68-77, 2016 07.
Article in English | MEDLINE | ID: mdl-27372059

ABSTRACT

Agent-based simulations are increasingly popular in exploring and understanding cellular systems, but the natural complexity of these systems and the desire to grasp different modelling levels demand cost-effective simulation strategies and tools. In this context, the present paper introduces novel sequential and distributed approaches for the three-dimensional agent-based simulation of individual molecules in cellular events. These approaches are able to describe the dimensions and position of the molecules with high accuracy and thus, study the critical effect of spatial distribution on cellular events. Moreover, two of the approaches allow multi-thread high performance simulations, distributing the three-dimensional model in a platform independent and computationally efficient way. Evaluation addressed the reproduction of molecular scenarios and different scalability aspects of agent creation and agent interaction. The three approaches simulate common biophysical and biochemical laws faithfully. The distributed approaches show improved performance when dealing with large agent populations while the sequential approach is better suited for small to medium size agent populations. Overall, the main new contribution of the approaches is the ability to simulate three-dimensional agent-based models at the molecular level with reduced implementation effort and moderate-level computational capacity. Since these approaches have a generic design, they have the major potential of being used in any event-driven agent-based tool.


Subject(s)
Computer Simulation , Models, Molecular , Systems Analysis , Intramolecular Oxidoreductases/chemistry
11.
Eur J Clin Microbiol Infect Dis ; 34(9): 1879-84, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26115631

ABSTRACT

The aim of this study was to assess the efficacy of and the risk of major bleeding during pegylated interferon (peg-IFN)/ribavirin (RBV) treatment among human immunodeficiency virus (HIV)/hepatitis C virus (HCV)-coinfected patients according to the pretreatment platelet count. Two hundred and seventy-four HCV/HIV-coinfected, previously naïve individuals with compensated cirrhosis enrolled in one Spanish prospective cohort who received peg-IFN/RBV were included in this study. The frequency of severe bleeding and sustained virological response (SVR) rate were compared between patients with a pretreatment platelet count ≤70,000/mm(3) and >70,000/mm(3), respectively. Sixty-one (22 %) patients had a baseline platelet count ≤70,000/mm(3). The median (Q1-Q3) pretreatment platelet count was 58,000 (49,000-65,000) cells/mm(3) in the platelet ≤70,000 group and 129,000 (102,500-166,000) cells/mm(3) in the platelet >70,000 group (p < 0.0001). Seventeen (28 %) subjects of the platelet ≤70,000 group and 71 (33 %) patients of the platelet >70,000 group achieved SVR (p = 0.4). Only 2 (3.2 %) patients in the platelet ≤70,000 group developed a severe hemorrhagic event, specifically esophageal variceal bleeding. The efficacy of therapy with peg-IFN/RBV in HIV/HCV-coinfected patients with low pretreatment platelet counts is comparable to that found in the overall subset of subjects with compensated cirrhosis. The frequency of severe hemorrhagic events related with this therapy is low in this population.


Subject(s)
Gastrointestinal Hemorrhage/pathology , HIV Infections/drug therapy , Hepatitis C, Chronic/drug therapy , Interferon-alpha/therapeutic use , Polyethylene Glycols/therapeutic use , Ribavirin/therapeutic use , Thrombocytopenia/complications , Adult , Antiviral Agents/therapeutic use , Cohort Studies , Coinfection/virology , Drug Therapy, Combination , Esophageal and Gastric Varices/pathology , Female , HIV Infections/complications , HIV Infections/virology , HIV-1/drug effects , Hepacivirus/drug effects , Hepatitis C, Chronic/complications , Hepatitis C, Chronic/virology , Humans , Male , Middle Aged , Platelet Count , Prospective Studies , Recombinant Proteins/therapeutic use , Risk , Spain , Treatment Outcome , Viral Load
12.
Mol Plant ; 2(2): 270-83, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19825613

ABSTRACT

The expression of the genes encoding the ferredoxin-thioredoxin system including the ferredoxin-thioredoxin reductase (FTR) genes ftrC and ftrV and the four different thioredoxin genes trxA (m-type; slr0623), trxB (x-type; slr1139), trxC (sll1057) and trxQ (y-type; slr0233) of the cyanobacterium Synechocystis sp. PCC 6803 has been studied according to changes in the photosynthetic conditions. Experiments of light-dark transition indicate that the expression of all these genes except trxQ decreases in the dark in the absence of glucose in the growth medium. The use of two electron transport inhibitors, 3-(3,4-dichlorophenyl)-1,1-dimethylurea (DCMU) and 2,5-dibromo-3-methyl-6-isopropyl-p-benzoquinone (DBMIB), reveals a differential effect on thioredoxin genes expression being trxC and trxQ almost unaffected, whereas trxA, trxB, and the ftr genes are down-regulated. In the presence of glucose, DCMU does not affect gene expression but DBMIB still does. Analysis of the single TrxB or TrxQ and the double TrxB TrxQ Synechocystis mutant strains reveal different functions for each of these thioredoxins under different growth conditions. Finally, a Synechocystis strain was generated containing a mutated version of TrxB (TrxBC34S), which was used to identify the potential in-vivo targets of this thioredoxin by a proteomic analysis.


Subject(s)
Bacterial Proteins/metabolism , Photosynthesis , Synechocystis/metabolism , Thioredoxins/metabolism , Blotting, Western , Chromatography, Affinity
13.
Biochem Pharmacol ; 78(3): 231-40, 2009 Aug 01.
Article in English | MEDLINE | ID: mdl-19389384

ABSTRACT

Thymidine phosphorylase (TP) is a catabolic enzyme in thymidine metabolism that is frequently upregulated in many solid tumors. Elevated TP levels are associated with tumor angiogenesis, metastasis and poor prognosis. Therefore, the use of TP inhibitors might offer a promising strategy for cancer treatment. The tritylated inosine derivative 5'-O-tritylinosine (previously designated KIN59) is a non-competitive inhibitor of TP which was previously found to be instrumental for the crystallization of human TP. A combination of computational studies including normal mode analysis, automated ligand docking and molecular dynamics simulations were performed to define a plausible binding site for 5'-O-tritylinosine on human TP. A cavity in which 5'-O-tritylinosine could fit was identified in the vicinity of the Gly405-Val419 loop at a distance of about 11A from the substrate-binding site. In the X-ray crystal structure, this pocket is characterized by an intricate hydrogen-bonding network in which Asp203 was found to play an important role to afford the loop stabilization that is required for efficient enzyme catalysis. Site-directed mutagenesis of this amino acid residue afforded a mutant enzyme with a severely compromised catalytic efficiency (V(max)/K(m) of mutant enzyme approximately 50-fold lower than for wild-type TP) and pronounced resistance to the inhibitory effect of 5'-O-tritylinosine. In contrast, the D203A mutant enzyme kept full sensitivity to the competitive inhibitors 6-aminothymine and 6-amino-5-bromouracil, which is in line with the kinetic properties of these inhibitors. Our findings reveal the existence of a previously unrecognized site in TP that can be targeted by small molecules to inhibit the catalytic activity of TP.


Subject(s)
Aspartic Acid/metabolism , Enzyme Inhibitors/pharmacology , Inosine/analogs & derivatives , Thymidine Phosphorylase/metabolism , Trityl Compounds/pharmacology , Amino Acid Sequence , Animals , Aspartic Acid/antagonists & inhibitors , Catalytic Domain , Crystallization , Crystallography, X-Ray , Humans , Hydrogen Bonding , Inosine/pharmacology , Kinetics , Models, Molecular , Molecular Sequence Data , Mutagenesis, Site-Directed , Sequence Homology, Amino Acid , Thymidine Phosphorylase/antagonists & inhibitors , Thymidine Phosphorylase/chemistry , Thymidine Phosphorylase/genetics
14.
Hum Vaccin ; 4(1): 54-9, 2008.
Article in English | MEDLINE | ID: mdl-18441530

ABSTRACT

The combined HB-Hib vaccine candidate Hebervac HB-Hib (CIGB, La Habana), comprising recombinant HBsAg and tetanus toxoid conjugate synthetic PRP antigens has shown to be highly immunogenic in animal models. A phase I open, controlled, randomized clinical trial was carried out to assess the safety and immunogenicity profile of this bivalent vaccine in 25 healthy adults who were positive for antibody to HBsAg (anti-HBs). The trial was performed according to Good Clinical Practices and Guidelines. Volunteers were randomly allocated to receive the combined vaccine or simultaneous administration of HB vaccine Heberbiovac-HB and Hib vaccine QuimiHib (CIGB, La Habana). All individuals were intramuscularly immunized with a unique dose of 10 microg HBsAg plus 10 microg conjugated synthetic PRP. Adverse events were actively recorded after vaccine administration. Total anti-HBs and IgG anti-PRP antibody titers were evaluated using commercial ELISA kits at baseline and 30 days post-vaccination. The combined vaccine candidate was safe and well tolerated. The most common adverse reactions were local pain, febricula, fever and local erythema. These reactions were all mild in intensity and resolved without medical treatment. Adverse events were mostly reported during the first 6-72 hours post-vaccination. There were no serious adverse events during the study. No severe or unexpected events were either recorded during the trial. The combined vaccine elicited an anti-HBs and anti-PRP booster response in 100% of subjects at day 30 of the immunization schedule. Anti-HBs and anti-PRP antibody levels had at least a two-fold increase compared to baseline sera. Even more, anti-HBs antibody titer showed a four-fold increase in 100% of volunteers in the study group. The results indicate that the combined HB-Hib vaccine produces increased antibody levels in healthy adults who have previously been exposed to these two antigens. To our knowledge, this is the first demonstration of safety and immunogenicity for a combined vaccine comprising recombinant HBV and synthetic Hib antigens. The present results support phase I-II clinical trial in the target population, two months old healthy infants.


Subject(s)
Bacterial Capsules/immunology , Haemophilus Vaccines/immunology , Hepatitis B Vaccines/immunology , Vaccines, Combined/adverse effects , Vaccines, Combined/immunology , Adult , Antibodies, Bacterial/blood , Bacterial Capsules/administration & dosage , Haemophilus Vaccines/administration & dosage , Haemophilus influenzae type b/immunology , Hepatitis B Antibodies/blood , Hepatitis B Antibodies/immunology , Hepatitis B Vaccines/administration & dosage , Hepatitis B Vaccines/adverse effects , Hepatitis B virus/genetics , Hepatitis B virus/immunology , Humans , Safety , Vaccines, Combined/administration & dosage , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/adverse effects
15.
Brain Res Bull ; 75(2-4): 480-4, 2008 Mar 18.
Article in English | MEDLINE | ID: mdl-18331918

ABSTRACT

The physiology of the mesencephalic reticular formation (MRF) in goldfish suggests its contribution to eye and body movements, but the afferent and efferent connections underlying such movements have not been determined. Therefore, we injected the bidirectional tracer biotinylated dextran amine into functionally identified MRF sites. We found retrogradely labelled neurons and anterogradely labelled boutons within nuclei of the following brain regions: (1) the telencephalon: a weak and reciprocal connectivity was confined to the central zone of area dorsalis and ventral nucleus of area ventralis; (2) the diencephalon: reciprocal connections were abundant in the ventral and dorsal thalamic nuclei; the central pretectal nucleus was also reciprocally wired with the MRF, but only boutons were present in the superficial pretectal nucleus; the preoptic and suprachiasmatic nuclei showed abundant neurons and boutons; the MRF was reciprocally connected with the preglomerular complex and the anterior tuberal nucleus; (3) the mesencephalon: neurons and boutons were abundant within deep tectal layers; reciprocal connections were also present within the torus semicircularis and the contralateral MRF; neurons were abundant within the nucleus isthmi; and (4) the rhombencephalon: the superior and middle parts of the reticular formation received strong projections from the MRF, while the projection to the inferior area was weaker; sparse neurons were present throughout the reticular formation; a reciprocal connectivity was observed with the sensory trigeminal nucleus; the medial and magnocellular nuclei of the octaval column projected to the MRF. These results support the participation of the MRF in the orienting response. The MRF could also be involved in other motor tasks triggered by visual, auditory, vestibular, or somatosensory signals.


Subject(s)
Goldfish/anatomy & histology , Reticular Formation/physiology , Afferent Pathways/physiology , Animals , Efferent Pathways/physiology , Reticular Formation/cytology
19.
Nucleosides Nucleotides Nucleic Acids ; 25(9-11): 975-80, 2006.
Article in English | MEDLINE | ID: mdl-17065049

ABSTRACT

We found that 5'-O-trityl-inosine (KIN59) inhibits recombinant bacterial (E. coli) and human thymidine phosphorylase (TPase) with an IC50 of 44 microM and 67 microM, respectively. In contrast to previously described TPase inhibitors, KIN59 does not compete with thymidine (dThd) at the pyrimidine nucleoside-binding site or with inorganic phosphate (Pi) at the phosphate-binding site of the enzyme. These findings are strongly suggestive for the presence of an allosteric binding site at the enzyme. TPase is identical to the angiogenic protein platelet-derived endothelial cell growth factor (PD-ECGF). As such, PD-ECGF stimulates angiogenesis in the chick chorioallantoic membrane (CAM) assay. This angiogenic response was completely inhibited by KIN59. Inosine did not inhibit the enzyme or the angiogenic effect of TPase, confirming that the 5'-O-trityl group in KIN59 is essential for the observed effect. Our observations indicate that allosteric sites in TPase may regulate its biological activity.


Subject(s)
Enzyme Inhibitors/pharmacology , Inosine/analogs & derivatives , Thymidine Phosphorylase/antagonists & inhibitors , Trityl Compounds/pharmacology , Allosteric Site , Animals , Chickens , Chorion/metabolism , Escherichia coli/enzymology , Humans , Inhibitory Concentration 50 , Inosine/pharmacology , Neoplasms/drug therapy , Neovascularization, Pathologic , Phosphates , Pyrimidines/chemistry , Thymidine Phosphorylase/metabolism
20.
Anat Embryol (Berl) ; 211(5): 465-73, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16763809

ABSTRACT

Neurotrophins acting through Trk signal-transducing receptors play essential roles in the nervous system, and probably in some non-neuronal tissues. In the present study, we used RT-PCR, Western-blot and immunohistochemistry to investigate the occurrence and cellular localization of TrkB in the mouse liver, from newborns to 6 months. Furthermore, the structure of the liver in mice carrying a mutation in the trkB gene, resulting in a non-functional protein, was studied. The analysis of the DNA sequence showed that hepatic trkB gene is identical to the cerebral one, and TrkB mRNA and TrkB full-length protein (145 kDa) were detected at all the ages sampled. Immunohistochemistry revealed age-dependent changes in the pattern of TrkB expression. From 0 to 15 days, the TrkB was detected in morphologically and immunohistochemically identified monocyte-macrophage-dendric cells scattered throughout the organ, while in animals 3- and 6-months-old it was restricted to nerve fibres. Interestingly, there was a parallelism between TrkB expression by monocyte-macrophage-dendric cells and the presence of hepatic erythroblastic islands. In agreement with a possible role of TrkB on hepatic haematopoiesis, the liver of 15 days old TrkB (-/-) mice still contained erythroblastic islands, whereas they were absent in the wild-type littermates. Another striking finding was the absence of nerve profiles in the TrkB (-/-) animals. All together, present results support the role of TrkB in the murine liver in maintaining the innervation of the organ, and more importantly throughout an unknown mechanism in controlling the hepatic haematopoietic function.


Subject(s)
Hematopoiesis, Extramedullary/physiology , Liver/physiology , Receptor, trkB/genetics , Receptor, trkB/metabolism , Age Factors , Animals , Dendritic Cells/physiology , Gene Expression Regulation, Developmental , Immunohistochemistry , Liver/cytology , Liver/growth & development , Macrophages/physiology , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Microscopy, Electron , Monocytes/physiology , Nerve Fibers/physiology , Nerve Fibers/ultrastructure , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL
...